Antibodies

A team of global scientists found an antibody-based therapeutic that they hope will stop the next rodent-borne hantavirus outbreak in its tracks.

COVID-19 researchers focus their studies on antibodies targeting exposed parts of SARS-CoV-2, but in a new study, a group of researchers showed that antibodies targeting proteins inside the virus are just as important for a robust immune response.

Some scientists use cancer patients as libraries for discovering novel immunotherapies.

Advanced diagnostic devices hold potential for achieving precision healthcare.

Learn how scientists integrate computational biology and experimental data to accelerate antibody drug development.

LIVE April 28th, 2022 at 10:00 AM
Researchers use ingenious strategies for breaking through the blood-brain barrier.

Small antibodies called nanobodies produced in camels, llamas, and alpacas might help stop the spread of COVID-19, but can they stand up against the competition?

Scientists leverage the natural ability of antibodies to cross the blood-brain barrier and target proteins implicated in neurodegenerative disease.

Investigating antibodies produced by infectious diseases yields vaccines with broad-acting protection.

LIVE June 30th, 2021 at 2:30 PM ET

In this webinar, scientists will discuss the emergence of SARS-CoV-2 variants and strategies for monitoring, tracking, and mitigating SARS-CoV-2 escape variants.